drugset

drugset / Trial / NCT01953419

Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy

NCT01953419 ↗

Phase 2 Completed 34 enrolled Sun Yat-sen University

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial aimed to assess the efficacy and safety of pemetrexed in patients with pretreated metastatic gastric cancer.

Timeline

Start: 2010-09
Primary completion: 2013-12
Completion: 2014-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pemetrexed	Small molecule	500 mg/m2	—

Indications